Kundl, Austria

Martin Albert

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Bruck am Ziller, AT (2012 - 2013)
  • Kundl, AT (2013 - 2014)
  • Kundl/Tyrol, AT (2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Martin Albert from Kundl, Austria**

Introduction

Martin Albert is a notable inventor hailing from Kundl, Austria. With a remarkable portfolio comprising seven patents, he has significantly contributed to the field of chemical innovations. His recent inventions focus on the synthesis of chiral compounds, which play a critical role in pharmaceutical applications.

Latest Patents

Among Martin Albert's latest patents is the innovative "Process for the preparation of chiral hydrazides." This invention pertains to a method for producing chiral compounds that can be utilized in the manufacture of antifungal agents, especially posaconazole. The process is characterized by its efficiency and specificity, particularly focusing on alkyl residues with a carbon range of 1 to 6.

Additionally, he has developed a "Process for the preparation of chiral triazolones." This method outlines a systematic approach to synthesizing chiral compounds, notably posaconazole, through a sequence of reactions involving various chemical formulas. This innovation illustrates Martin's adeptness in the area of organic chemistry and medicinal development.

Career Highlights

Martin Albert currently contributes his expertise at Sandoz AG, a leading global company in the field of generic pharmaceuticals and biosimilars. His work has not only advanced individual projects but has also enriched the company's research and development goals, focusing on potent therapeutic agents.

Collaborations

Throughout his career, Martin has had the opportunity to collaborate with esteemed colleagues, including Dominic De Souza and Hubert Sturm. These partnerships have fostered a collaborative environment that promotes creativity and innovation, allowing for the productive exchange of ideas and technological advancements.

Conclusion

Martin Albert's journey as an inventor showcases his commitment to innovation within the pharmaceutical industry. With his recent advancements in chiral compound synthesis, he continues to push the boundaries of scientific research. His work not only benefits Sandoz AG but also enriches the broader scientific community, paving the way for future breakthroughs in medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…